| Dr Kimberly A Wooldridge, PSYD | |
|
2100 Napa Vallejo Hwy, Napa, CA 94558-6234 | |
| (707) 253-5017 | |
| Not Available |
| Full Name | Dr Kimberly A Wooldridge |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2100 Napa Vallejo Hwy, Napa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831468529 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly A Wooldridge, PSYD 2980 Chase Ridge Drive, Middleburg, FL 32068 Ph: (904) 505-7624 | Dr Kimberly A Wooldridge, PSYD 2100 Napa Vallejo Hwy, Napa, CA 94558-6234 Ph: (707) 253-5017 |
News Archive
The high court let stand a lower court ruling rejecting an Indiana law that would have banned Planned Parenthood from receiving any Medicaid funds.
In patients undergoing hip replacement surgery, using a special wound catheter to infuse local anesthetic directly into the hip joint provides significant and lasting improvements in postoperative pain control, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Justices will hear arguments today regarding California's plan to cut Medicaid payments to doctors, hospitals and other medical providers in an effort to address the state's budget issues. Experts say the case has national implications because its central issue involves states' rights to regulate their Medicaid programs.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.
› Verified 2 days ago
Dr. Steven Jin Choi, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-254-2712 Fax: 707-253-5097 | |
Mr. Benjamin Joseph Levin, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5631 | |
Joan Dittrich, PH D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1141 Division St, Napa, CA 94559 Phone: 707-258-1426 | |
Brittany Alyce Cunningham, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5654 | |
Dr. Michael Kelley, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 553 Jefferson St, Napa, CA 94559 Phone: 707-337-0470 | |
Dr. Kristopher M Thomas, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5460 | |
Dr. Jo Gilbert, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1303 Jefferson St, Ste. 600a, Napa, CA 94559 Phone: 707-224-2893 Fax: 707-224-2894 |